Barlow’s Syndrome market research report: by type (mitral valve stenosis), treatment (medication and surgical treatment), diagnosis (X-Ray, and Echocardiogram), end-users (hospitals & surgical centers, and specialty clinics) – Global forecast till 2027
ID: MRFR/MED/4147-HCR | February 2021 | Region: Global | 105 pages
Market Scenario:
Barlow’s syndrome is an abnormality of the mitral valve of the heart. It is a condition in which the leaflets of the mitral valve swell and shifts towards to the left atrium of the heart as the valve closes during ventricular contraction. This abnormality prevents the valve from closing suitably, which causes it to leak.
Barlow’s Syndrome can be caused by various reasons, some of them are calcium buildup, congenital heart defects, radiation treatment, and tumors. Additionally, traumatic injury, disease, or infection can lead to Barlow’s Syndrome.
The global Barlow’s Syndrome market is estimated to lead a healthy growth. The global Barlow’s Syndrome market is majorly driven by increasing geriatric population, rising global population, and rising cardiovascular disorders. According to a report published by the U.S. Population Reference Bureau, nearly 46 million people aged 65 years or more in 2014, and the report estimates that this number would double to reach nearly 98 million people by the end of 2060. Similarly, the 65-and-older age group would reach up to nearly 24% by 2030 from 15% as of 2015.
Global Barlow’s Syndrome market is expected to grow at a CAGR of 9% during the forecast period.
Figure: Global Barlow’s Syndrome market, by region, 2017 (%)
Source: World Health Organization, Centers for Disease Control and Prevention, expert interview, market research future analysis, annual report, white paper, company presentation
Intended Audience
- Pharmaceutical Manufacturers and Suppliers
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Research Methodology:
Source: World Health Organization, Centers for Disease Control and Prevention, expert interview, market research future analysis, annual report, white paper, company presentation
Segments
The global Barlow’s Syndrome market is segmented on the basis of type, treatment, diagnosis, and end-users.
On the basis of the type, the market is segmented as mitral valve stenosis, mitral valve prolapse, and mitral valve regurgitation.
On the basis of the treatment, the market is segmented into medications and surgery. The medications are further sub-segmented into beta-blockers and calcium blockers. Beta-blockers further sub-segmented into Atenolol and Metoprolol. Calcium blockers further sub-segmented into Verapamil and Diltiazem.
On the basis of the diagnosis, the market is segmented into X-ray, Electrocardiogram, and Echocardiogram.
On the basis of the end user, the market is segmented into hospitals & surgical centers, research institutes, and specialty clinics.
Regional Analysis
North America holds the maximum share of the global Barlow’s Syndrome market in the Americas region. On a regional basis, the Americas region is segmented into North America and South America. North America is segmented into the U.S. and Canada. Increasing geriatric population, rising number of cardiovascular disorders, and growing population have increased the scope of the Barlow’s Syndrome market in the North American market.
Europe holds the second largest share of the global Barlow’s Syndrome market. The European market is expected to grow at a healthy growth during the forecasted period. Various Factors such as availability of advanced treatment facilities, increasing cardiovascular diseases, and skilled medical professionals are propelling the growth of Barlow’s Syndrome market in the European region. For instance, according to the European Heart Network, cardiovascular disorders accounted for 45% of the total deaths in 2015. Additionally, increasing government healthcare initiatives and growing research and development activities supported by the government to provide better healthcare treatments are likely to boost the market growth.
The Asia Pacific is expected to be the fastest growing market owing to increasing incidence of chronic diseases, and fetal disorders. India is the fastest growing region owing to increasing population and increasing geriatric population. Rising awareness, growing standard of living, and availability of new treatment methods are likely to drive the market growth in this region.
The Middle East & Africa is expected to show steady growth in the market . Major factors that are affecting the growth are lack of awareness, and limited access and availability of treatment facilities. In the Middle East, United Arab Emirates has accounted for the largest market share owing to the development of healthcare infrastructure, skilled healthcare providers.
Key Players
Some of the key players in the barlows syndrome market are Abbott, Medtronic, CryoLife, Inc., Lepu Medical Technology Co., Ltd. Boston Scientific Corporation, Micro Interventional Devices, Inc., Neovasc, Inc., Edward Lifesciences Corporation, Sorin Group, TTK HealthCare, and JenaValve Technology, Inc
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2027: Significant Value |
| CAGR | 9% (2018-2025) |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Treatment, Diagnosis, and End-users |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Abbott, Medtronic, CryoLife, Inc., Lepu Medical Technology Co., Ltd. Boston Scientific Corporation, Micro Interventional Devices, Inc., Neovasc, Inc., Edward Lifesciences Corporation, Sorin Group, TTK HealthCare, and JenaValve Technology, Inc |
| Key Market Opportunities | New product launches and R&D Amongst major key Players |
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
Barlow’s syndrome is an abnormality of the mitral valve of the heart. It is a condition in which the leaflets of the mitral valve swell and shift towards to the left atrium of the heart as the valve closes during ventricular contraction. This abnormality prevents the valve from closing suitably, which causes it to leak.
The market is expected to exhibit a strong 9% CAGR over the forecast period from 2017 to 2023.
The increasing geriatric population is a major driver for the Barlow’s Syndrome Market.
The Americas hold the largest share in the Global Barlow’s Syndrome Market.
Leading players in the Barlow’s syndrome market include Abbott, Medtronic, and CryoLife, among others.
Table Of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
6. Global Barlow’s Syndrome Market, By Type
6.1 Introduction
6.2 Mitral Valve Stenosis
6.2.1 Market Estimates & Forecast, 2020-2027
6.3 Mitral Valve Prolapse
6.3.1 Market Estimates & Forecast, 2020-2027
6.4 Mitral Valve Regurgitation
6.4.1 Market Estimates & Forecast, 2020-2027
7. Global Barlow’s Syndrome Market, By Treatment
7.1 Introduction
7.2 Medication
7.2.1 Beta-Blockers
7.2.1.1 Atenolol
7.2.1.2 Metoprolol
7.2.1.3 Propranolol
7.2.2 Calcium Blockers
7.2.2.1 Verapamil
7.2.22 Diltiazem
7.2.3 Market Estimates & Forecast, 2020-2027
7.3 Surgery
7.3.1 Market Estimates & Forecast, 2020-2027
8. Global Barlow’s Syndrome Market, By Diagnosis
8.1 Introduction
8.2 X-Ray
8.2.1 Market Estimates & Forecast, 2020-2027
8.3 Electrocardiogram
8.3.1 Market Estimates & Forecast, 2020-2027
8.4 Echocardiogram
8.4.1 Market Estimates & Forecast, 2020-2027
9. Global Barlow’s Syndrome Market, By End User
9.1 Introduction
9.2 Hospitals & Surgical Centers
8.2.1 Market Estimates & Forecast, 2020-2027
8.3 Research Institutes
8.3.1 Market Estimates & Forecast, 2020-2027
8.4 Specialty Clinics
8.4.1 Market Estimates & Forecast, 2020-2027
9 Global Barlow’s Syndrome Market, By Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 U.S.
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 U.K.
9.3.1.4 Italy
9.3.1.5 Spain
9.3.1.6 Rest Of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic Of Korea
9.4.6 Rest Of Asia Pacific
9.5 The Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Oman
9.5.4 Kuwait
9.5.5 Qatar
9.5.6 Rest Of The Middle East & Africa
10 Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
10.3.1 Key Developments
11 Company Profiles
11.1 Abbott Laboratories, Inc.,
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials
11.1.4 SWOT Analysis
11.2 Biotronik Pvt Ltd
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Colibri Heart Valve
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Edward Lifesciences
11.4.1 Company Overview
11.4.2 Product/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 HLT Medical
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial Overview
11.5.4 Key Developments
11.6 Medtronic Plc
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.7 LivaNova Plc
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Others
12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s View Point
12.1.2 Unmet Needs Of The Market
12.2 Key Companies To Watch
12.3 Prediction Of Pharmaceutical Industry
13 Appendix
LIST OF TABLES
Table 1 Barlow’s Syndrome Industry Synopsis, 2020-2027
Table 2 Global Barlow’s Syndrome Market Estimates And Forecast, 2020-2027, (USD Million)
Table 3 Global Barlow’s Syndrome Market By Region, 2020-2027, (USD Million)
Table 5 Global Barlow’s Syndrome Market By Treatment, 2020-2027, (USD Million)
Table 6 Global Barlow’s Syndrome Market By Diagnosis, 2020-2027, (USD Million)
Table 7 Global Barlow’s Syndrome Market By End Users, 2020-2027, (USD Million)
Table 8 North America Barlow’s Syndrome Market By Treatment, 2020-2027, (USD Million)
Table 9 North America Barlow’s Syndrome Market By Daignosis, 2020-2027, (USD Million)
Table 10 North America Barlow’s Syndrome Market By End Users, 2020-2027, (USD Million)
Table 11 US Barlow’s Syndrome Market By Treatment, 2020-2027, (USD Million)
Table 12 US Barlow’s Syndrome Market By Daignosis, 2020-2027, (USD Million)
Table 13 US Barlow’s Syndrome Market By End Users, 2020-2027, (USD Million)
Table 14 Canada Barlow’s Syndrome Market By Treatment, 2020-2027, (USD Million)
Table 15 Canada Barlow’s Syndrome Market By Daignosis, 2020-2027, (USD Million)
Table 16 Canada Barlow’s Syndrome Market By End Users, 2020-2027, (USD Million)
Table 17 South America Barlow’s Syndrome Market By Treatment, 2020-2027, (USD Million)
Table 18 South America Barlow’s Syndrome Market By Daignosis, 2020-2027, (USD Million)
Table 19 South America Barlow’s Syndrome Market By End Users, 2020-2027, (USD Million)
Table 20 Europe Barlow’s Syndrome Market By Treatment, 2020-2027, (USD Million)
Table 21 Europe Barlow’s Syndrome Market By Daignosis, 2020-2027, (USD Million)
Table 22 Europe Barlow’s Syndrome Market By End Users, 2020-2027, (USD Million)
Table 23 Western Europe Barlow’s Syndrome Market By Treatment, 2020-2027, (USD Million)
Table 24 Western Europe Barlow’s Syndrome Market By Daignosis, 2020-2027, (USD Million)
Table 25 Western Europe Barlow’s Syndrome Market By End Users, 2020-2027, (USD Million)
Table 26 Eastern Europe Barlow’s Syndrome Market By Treatment, 2020-2027, (USD Million)
Table 27 Eastern Europe Barlow’s Syndrome Market By Daignosis, 2020-2027, (USD Million)
Table 28 Eastern Europe Barlow’s Syndrome Market By End Users, 2020-2027, (USD Million)
Table 29 Asia Pacific Barlow’s Syndrome Market By Treatment, 2020-2027, (USD Million)
Table 30 Asia Pacific Barlow’s Syndrome Market By Daignosis, 2020-2027, (USD Million)
Table 31 Asia Pacific Barlow’s Syndrome Market By End Users, 2020-2027, (USD Million)
Table 32 Middle East & Africa Barlow’s Syndrome Market By Treatment, 2020-2027, (USD Million)
Table 33 Middle East & Africa Barlow’s Syndrome Market By Daignosis, 2020-2027, (USD Million)
Table 34 Middle East & Africa Barlow’s Syndrome Market By End Users, 2020-2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Global Barlow’s Syndrome Market
Figure 3 Segmentation Market Dynamics For Barlow’s Syndrome Market
Figure 4 Global Barlow’s Syndrome Market Share, By Treatment 2020
Figure 5 Global Barlow’s Syndrome Market Share, By Diagnosis 2020
Figure 6 Global Barlow’s Syndrome Market Share, By End Users, 2020
Figure 7 Global Barlow’s Syndrome Market Share, By Region, 2020
Figure 8 North America Barlow’s Syndrome Market Share, By Country, 2020
Figure 9 Europe Barlow’s Syndrome Market Share, By Country, 2020
Figure 10 Asia Pacific Barlow’s Syndrome Market Share, By Country, 2020
Figure 11 Middle East & Africa Barlow’s Syndrome Market Share, By Country, 2020
Figure 12 Global Barlow’s Syndrome Market: Company Share Analysis, 2020 (%)
Figure 13 Abbott Laboratories, Inc: Key Financials
Figure 14 Abbott Laboratories, Inc: Segmental Revenue
Figure 16 Abbott Laboratories, Inc: Geographical Revenue
Figure 17 Biotronik Pvt Ltd: Key Financials
Figure 18 Biotronik Pvt Ltd: Segmental Revenue
Figure 19 Biotronik Pvt Ltd: Geographical Revenue
Figure 20 Colibri Heart Valve: Key Financials
Figure 21 Colibri Heart Valve: Segmental Revenue
Figure 22 Colibri Heart Valve Geographical Revenue
Figure 23 Edward Lifesciences: Key Financials
Figure 24 Edward Lifesciences: Segmental Revenue
Figure 25 Edward Lifesciences: Geographical Revenue
Figure 26 HLT Medical: Key Financials
Figure 27 HLT Medical: Segmental Revenue
Figure 28 HLT Medical: Geographical Revenue
Figure 29 LivaNova Plc: Key Financials
Figure 30 LivaNova Plc: Segmental Revenue
Figure 31 LivaNova Plc: Geographical Revenue
Figure 32 Medtronic. Key Financials
Figure 33 Medtronic. Segmental Revenue
Figure 34 Medtronic. Geographical Revenue